MINISO Group Announces December Quarter 2021 Results
MINISO Group Holding Limited (NYSE: MNSO) (“MINISO”, “MINISO Group” or the “Company”), a fast-growing global value retailer offering a variety… Read More »
Boqii Announces Fiscal 2022 Third Quarter Unaudited Financial Results
Boqii Holding Limited (“Boqii” or the “Company”) (NYSE: BQ), a leading pet-focused platform in China, today announced its unaudited financial results… Read More »
I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific Antibody TJ-CD4B for the Treatment of Gastric Cancer
I-Mab (the “Company”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today… Read More »
NASA Supported Reality Show ‘Space Hero’ inks Asia Partnership Deal With One Digital Entertainment
The reality show will send a civilian into space for a 6-day mission orbiting Earth and synching with the ISS… Read More »
Claudin18.2 CAR T Cells (CT041) Receives Approval to Initiate A Confirmatory Phase II Clinical Trial for advanced GC/GEJ in China
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of… Read More »
Baidu Launches AI Platform to Enable on-Device, Real-Time Translation from Speech to Hand Gestures
Baidu AI Cloud, a leading AI cloud provider, launched an AI sign language platform able to generate digital avatars for… Read More »
USI Helps Customers Launch Edge AI Computing Servers
The importance of edge computing has become increasingly prominent. USI’s data network storage product line is committed to providing ODM/JDM/EMS… Read More »
Prince Mohammad Bin Fahd University Embraces the Digital Transformation of Higher Education in a World Changed by the COVID-19 Pandemic
Over the last quarter-century, the meteoric rise of the internet and portable electronic devices has swiftly transformed education. Over just… Read More »
Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications
Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or… Read More »
Inspiration Capital Partners Completes its Acquisition of Antute
Inspiration Capital Partners (“ICP”) today announced that it has completed its acquisition of Antute (Beijing) Technology Limited (“Antute”), a leading… Read More »